Early Growth of Infantile Hemangiomas: What Parents’ Photographs Tell Us

@article{Tollefson2012EarlyGO,
  title={Early Growth of Infantile Hemangiomas: What Parents’ Photographs Tell Us},
  author={Megha M. Tollefson and Ilona J Frieden},
  journal={Pediatrics},
  year={2012},
  volume={130},
  pages={e314 - e320}
}
BACKGROUND AND OBJECTIVES: Infantile hemangiomas (IH) are recognized as growing rapidly during the first months of life, but details of early growth before 3 months of age have not been well-characterized. Our goal was to study early IH growth by using parental photographs of infant children with facial IHs to better understand early hemangioma growth, with the aim of improving guidance for physicians and parents of infants with high-risk IH. METHODS: Serial images of 30 infants showing IH at… 

Figures and Tables from this paper

Automatic Assessment of Infantile Hemangiomas
TLDR
Evaluated methodologies for the segmentation of infantile Hemangiomas found the shortest path method revealed itself the best, as it is the one that can provide a better approximation between the segmented border and the real one.
Infantile Hemangioma: An Updated Review.
TLDR
Treatment of infantile hemangiomas should be individualized, depending upon the size, rate of growth, morphology, number and location of the lesion (s), existing or potential complications, benefits and adverse events associated with the treatment, age of the patient, level of parental concern, and the physician's comfort level with the various treatment options.
Large Infantile Hemangioma on the Face : Let’s ‘PHACE’ It
TLDR
Complicated IH like the one described here can be treated safely and effectively with propranolol; very early treatment initiation is recommended to prevent the development of anatomic deformities.
Infantile hemangiomas: new frontiers.
  • A. Yan
  • Medicine
    Pediatric annals
  • 2012
TLDR
Anatomic sites with hemangiomas that could become problematic therefore ideally should be evaluated before 8 weeks of age so that effective interventions can be initiated and earlier intervention may provide an improved outcome for affected infants.
Infantile Hemangioma : A Brief Review of Clinical Manifestations , Associations and Treatment
TLDR
Oral propranolol can be used to halt growth and cause regression in IH that are at high risk for developing complications, including ulceration, disfigurement, or impairment of essential functions (e.g. vision or breathing).
Clinical and radiological outcomes of infantile hemangioma treated with oral propranolol: A long‐term follow‐up study
TLDR
Despite propranolol treatment, surgery was still needed in 37.5% of IH at a mean age of 70.3 months, and for the main reason of surgery, fibrofatty or hemangioma residua, MRI was useful for choosing an appropriate surgical procedure.
Treatment of rapidly proliferating haemangiomas in newborns with propranolol and review of the literature
TLDR
There is need for larger scale studies confirming the safety and efficacy of propranolol in treatment of haemangiomas in newborns, as three patients showed excellent response with resolution of the lesion and fourth patient showed good result with >50% reduction of IH.
Update on infantile hemangioma
  • H. Jung
  • Medicine
    Clinical and experimental pediatrics
  • 2021
TLDR
Primary care clinicians frequently monitor infants with IHs, educate the parents about the clinical course, and refer infants with high-risk IH to IH specialists ideally at 1 month of age, according to the 2019 American Academy of Pediatrics clinical practice guideline.
Medical Management of Infantile Hemangiomas: An Update
TLDR
The clinical features, associations, complications/sequelae and therapeutic approaches for IH are reviewed, focusing on current medical therapy, including propranolol and other oral β-blockers, topical timolol, and corticosteroids.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 21 REFERENCES
Growth Characteristics of Infantile Hemangiomas: Implications for Management
TLDR
Most infantile hemangioma growth occurs before 5 months, yet 5 months was also the mean age at first visit to a specialist, and recognition of growth characteristics and factors that predict the need for follow-up could help aid in clinical decision-making.
Infantile hemangiomas with unusually prolonged growth phase: a case series.
TLDR
Prolonged growth was observed primarily in IHs with a deep component and segmental morphologic characteristics, and recognition of this subset of hemangiomas is important for clinicians, and further study of these lesions may provide clues to their pathogenesis.
Untreated Hemangiomas: Growth Pattern and Residual Lesions
TLDR
Epidermal invasion of the hemangioma is of predictive value for residual lesions and may add to a more detailed prediction of outcome and may help to decide which patient should be treated or not.
Infantile hemangiomas with minimal or arrested growth: a retrospective case series.
TLDR
Clinical characteristics of infantile hemangiomas with minimal or arrested growth have a distinct clinical appearance and a unique predilection for the lower body, and recognition of IH-MAGs will help in more accurate diagnosis of vascular birthmarks of infancy.
Propranolol for Severe Infantile Hemangiomas: Follow-Up Report
TLDR
Propranolol administered orally at 2 to 3 mg/kg per day has a consistent, rapid, therapeutic effect, leading to considerable shortening of the natural course of IHs, with good clinical tolerance.
Prospective Study of Infantile Hemangiomas: Clinical Characteristics Predicting Complications and Treatment
TLDR
Large size, facial location, and/or segmental morphology are the most important predictors of poor short-term outcomes as measured by complication and treatment rates in infantile hemangiomas.
Multicenter prospective study of ulcerated hemangiomas.
Hemangiomas of infancy: clinical characteristics, morphologic subtypes, and their relationship to race, ethnicity, and sex.
TLDR
Hemangiomas of infancy can usually be classified as localized, segmental, indeterminate, and multifocal, but this type of hemangioma seems to present with increased frequency in Hispanic infants.
Oral Propranolol Therapy for Infantile Hemangiomas Beyond the Proliferation Phase: A Multicenter Retrospective Study
TLDR
It is concluded that propranolol is effective in infantile hemangiomas, including post‐proliferative phase, and should be considered as the first‐line therapy in that setting.
...
1
2
3
...